Hillman Value holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Hillman Value Fund HCMAX
- NAV / 1-Day Return 28.24 / −0.95 %
- Total Assets 79.3M
-
Adj. Expense Ratio
0.950%
- Expense Ratio 0.950%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Large Value
- Investment Style Mid Value
- Min. Initial Investment 5,000
- Status Open
- TTM Yield 2.40%
- Turnover 42%
USD | NAV as of Jul 18, 2026 | 1-Day Return as of Jul 18, 2026, 12:31 AM GMT+0
Morningstar’s Analysis HCMAX
Will HCMAX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 30.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Umb Cash Deposit Sweep | 3.45 | 3M | Cash and Equivalents |
West Pharmaceutical Services Inc | 3.25 | 3M | Healthcare |
Veeva Systems Inc Class A | 3.17 | 2M | Healthcare |
CVS Health Corp | 3.10 | 2M | Healthcare |
Baxter International Inc | 3.08 | 2M | Healthcare |
United Parcel Service Inc Class B | 3.06 | 2M | Industrials |
Warner Bros. Discovery Inc Ordinary Shares - Class A | 2.98 | 2M | Communication Services |
DuPont de Nemours Inc | 2.96 | 2M | Basic Materials |
Taiwan Semiconductor Manufacturing Co Ltd ADR | 2.92 | 2M | Technology |
The Kraft Heinz Co | 2.87 | 2M | Consumer Defensive |